NHS-PEG4-(m-PEG4)3-ester Size:Contact [email protected] for quotation InChi: InChI=1S/C9H11N5O4/c10-9-13-7-5(8(18)14-9)12-3(1-11-7)6(17)4(16)2-15/h1

InChi: InChI=1S/C9H11N5O4/c10-9-13-7-5(8(18)14-9)12-3(1-11-7)6(17)4(16)2-15/h1

Smiles: C[C@@H](O)[C@H](NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1C=CC=CC=1)C(O)=O

SAR-260301 treatment leads to a statistically significant tumor growth inhibition as measured by a ΔT/ΔC of 39% (p = 0

11-29)12-37-26/h2-8

NHS-PEG4-(m-PEG4)3-ester Size:Contact [email protected] for quotation InChi: InChI=1S/C9H11N5O4/c10-9-13-7-5(8(18)14-9)12-3(1-11-7)6(17)4(16)2-15/h1NHS PEG4 (m PEG4)3 ester is a PEG based PROTAC linker that can be used in the synthesis of PROTACs. Product information CAS Number: 1333154 70 3 Molecular Weight: 1363. 54 Formula: C60H110N6O28 Chemical Name: 2,5 dioxopyrrolidin 1 yl 4 [(14 {[1,3 bis({2 [(2,5,8,11 tetraoxatridecan 13 yl)carbamoyl]ethoxy}) 2 ({2 [(2,5,8,11 tetraoxatridecan 13 yl)carbamoyl]ethoxy}methyl)propan 2 yl]carbamoyl} 3,6,9,12 tetraoxatetradecan 1 yl)carbamoyl]butanoate Smiles: